نتائج البحث - "Vahidnezhad, Hassan"

1

دورية أكاديمية

FLT3L governs the development of partially overlapping hematopoietic lineages in humans and mice

المؤلفون: Momenilandi, Mana, Lévy, Romain, Sobrino, Steicy, Li, Jingwei, Lagresle-Peyrou, Chantal, Esmaeilzadeh, Hossein, Fayand, Antoine, Le Floc’h, Corentin, Guérin, Antoine, Mina, Erika, Della, Shearer, Debra, Delmonte, Ottavia, M, Yatim, Ahmad, Mulder, Kevin, Mancini, Mathieu, Rinchai, Darawan, Denis, Adeline, Neehus, Anna-Lena, Balogh, Karla, Brendle, Sarah, Rokni-Zadeh, Hassan, Changi-Ashtiani, Majid, Seeleuthner, Yoann, Deswarte, Caroline, Bessot, Boris, Cremades, Cassandre, Materna, Marie, Cederholm, Axel, Ogishi, Masato, Philippot, Quentin, Beganovic, Omer, Ackermann, Mania, Wuyts, Margareta, Khan, Taushif, Fouéré, Sébastien, Herms, Florian, Chanal, Johan, Palterer, Boaz, Bruneau, Julie, Molina, Thierry, J, Leclerc-Mercier, Stéphanie, Prétet, Jean-Luc, Youssefian, Leila, Vahidnezhad, Hassan, Parvaneh, Nima, Claeys, Kristl, G, Schrijvers, Rik, Luka, Marine, Pérot, Philippe, Fourgeaud, Jacques, Nourrisson, Céline, Poirier, Philippe, Jouanguy, Emmanuelle, Boisson-Dupuis, Stéphanie, Bustamante, Jacinta, Notarangelo, Luigi, D, Christensen, Neil, Landegren, Nils, Abel, Laurent, Marr, Nico, Six, Emmanuelle, Langlais, David, Waterboer, Tim, Ginhoux, Florent, Ma, Cindy, S, Tangye, Stuart, G, Meyts, Isabelle, Lachmann, Nico, Hu, Jiafen, Shahrooei, Mohammad, Bossuyt, Xavier, Casanova, Jean-Laurent, Béziat, Vivien

المساهمون: Human genetics of infectious diseases: Complex predisposition (Equipe Inserm U1163), Imagine - Institut des maladies génétiques (IHU) (Imagine - U1163), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Service d'immuno-hématologie pédiatrique CHU Necker, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Necker - Enfants Malades AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Chromatin and gene regulation during development, Human Lymphohematopoiesis Laboratory (Equipe Inserm U1163), Pennsylvania State University (Penn State), Penn State System, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Shiraz University of Medical Sciences Iran (SUMS), CHU Tenon AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), University of Sydney, Sydney NSW 2006 Australia, Garvan Institute of medical research, Institut Gustave Roussy (IGR), Université Paris-Saclay, McGill University = Université McGill Montréal, Canada, Hôpital Lariboisière-Fernand-Widal APHP, Immunologie humaine, physiopathologie & immunothérapie (HIPI (UMR_S_976 / U976)), Institut Cochin (IC UM3 (UMR 8104 / U1016)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), National Institute of Allergy and Infectious Diseases Bethesda (NIAID-NIH), National Institutes of Health Bethesda, MD, USA (NIH), Département de Pathologie CHU Necker, Université Sorbonne Paris Cité (USPC)-Hôpital Necker - Enfants Malades AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Cité (UPCité), Centre National de Référence des Papillomavirus (CNRP), Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), University of California Los Angeles (UCLA), University of California (UC), University Hospitals Leuven Leuven, Catholic University of Leuven = Katholieke Universiteit Leuven (KU Leuven), Découverte de pathogènes – Pathogen discovery, Institut Pasteur Paris (IP)-Université Paris Cité (UPCité), Fédération pour la recherche en explorations et thérapeutiques innovantes in utéro (FETUS (URP 7328)), Université Paris Cité (UPCité), Microbes, Intestin, Inflammation et Susceptibilité de l'Hôte (M2iSH), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre de Recherche en Nutrition Humaine d'Auvergne (CRNH d'Auvergne)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)-Université Clermont Auvergne (UCA), Centre national de Référence Cryptosporidioses, microsporidies et autres protozooses digestives CHU Clermont Ferrand (CNR - laboratoire associé), CHU Gabriel Montpied Clermont-Ferrand, CHU Clermont-Ferrand-CHU Clermont-Ferrand, Rockefeller University New York, Hamad Bin Khalifa University Doha, Qatar (HBKU), German Cancer Research Center - Deutsches Krebsforschungszentrum Heidelberg (DKFZ), Howard Hughes Medical Institute (HHMI), This study was supported by the St. Giles Foundation, Rockefeller University, Institut National de la Santé et de la Recherche Médicale (INSERM), Paris Cité University, National Center for Research Resources, National Institutes of Health (NIH) (R01AI143810), National Center for Advancing Sciences of the National Institutes of Health (UL1TR001866), French National Research Agency (ANR) (ANR-10-IAHU-01, ANR-21-CE15-0034, and ANR-10-LABX-62-IBEID), ITMO Cancer of Aviesan and INCa within the framework of the 2021–2030 Cancer Control Strategy, C1 grant from KU Leuven (C16/18/007), French Society of Dermatology (SFD), the Schlumberger Foundation for teaching and research (FSER) (FSER202302017062), Square Foundation, Stavros Niarchos Foundation (SNF) as part of its grant to the SNF Institute for Global Infectious Disease Research at The Rockefeller University, William E. Ford (General Atlantic’s chairman and chief executive officer), Gabriel Caillaux (General Atlantic’s co-president, managing director, and head of business in EMEA), General Atlantic Foundation, ANRS—Maladies infectieuses émergentes (M. Momenilandi, ECTZ173053), American Association of Immunologists (A.G.), National Health and Medical Research Council of Australia (S.G.T. and C.S.M.), French Foundation for Medical Research (A.-L.N., FDT202204015102), Bettencourt-Schueller Foundation (A.-L.N.), Ecole de l’INSERM Liliane Bettencourt (Q.P.), David Rockefeller Graduate Program (M.O.), New York Hideyo Noguchi Memorial Society (M.O.), Funai Foundation for Information Technology (M.O.), Honjo International Scholarship Foundation (M.O.), New York Hideyo Noguchi Memorial Society (M.O.), Swedish Research Council and the Göran Gustafsson Foundation (N. Landegren), National Institute of Dental and Craniofacial Research program (J.H., R21DE028650), National Cancer Institute (J.H., R21CA271069 and R21 CA274265-01A1), National Institute of Allergy and Infectious Diseases (J.H. and N.C., R21AI121822), Penn State Cancer Institute Program Project Development Award Sponsored by the Highmark Community Health Reinvestment Fund and the Jake Gittlen Memorial Golf Tournament (J.H. and N.C.), FWO Vlaanderen (I.M., senior clinical researcher at FWO Vlaanderen, FWO G0B5120N, R.S., FWO 1805523N), European Research Council (I.M., no. 948959), and CSL Behring (I.M.). L.D.N. is supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, Bethesda (USA). Open access funding was provided by Rockefeller University., ANR-21-CE15-0034,CARMIL2,Bases moléculaires, cellulaires et immunologiques de la déficience combinée résultant de mutations dans CARMIL2(2021), ANR-10-IAHU-0001,Imagine,Institut Hospitalo-Universitaire Imagine(2010), ANR-10-LABX-0062,IBEID,Integrative Biology of Emerging Infectious Diseases(2010)

المصدر: ISSN: 0092-8674.

مصطلحات موضوعية: B cells, FLT3, FLT3L, FLT3LG, NK cells, dendritic cells, hematopoiesis, human, papillomavirus, primary immunodeficiency, [SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics, [SDV.IMM]Life Sciences [q-bio]/Immunology